Corbus Pharmaceuticals' GAAP loss for 3 months of 2022 was $9.437 million, down 41.3% from $16.065 million in the previous year. The company did not generate revenue in the period. In the same period last year, revenue was $647,824 thousand a year earlier.
Corbus Pharmaceuticals' GAAP loss for 3 months of 2022 was $9.437 million, down 41.3% from $16.065 million in the previous year. The company did not generate revenue in the period. In the same period last year, revenue was $647,824 thousand a year earlier. 
ir.corbuspharma.com
English (US) 